These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

687 related articles for article (PubMed ID: 31851008)

  • 1. The Randomized Controlled Trials Rehabilitation Checklist: Methodology of Development of a Reporting Guideline Specific to Rehabilitation.
    Negrini S; Armijo-Olivo S; Patrini M; Frontera WR; Heinemann AW; Machalicek W; Whyte J; Arienti C;
    Am J Phys Med Rehabil; 2020 Mar; 99(3):210-215. PubMed ID: 31851008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current Evidence From the Randomized Controlled Trials Rehabilitation Checklist (RCTRACK) reporting guideline project.
    Negrini S; Chan L; Ferriero G; Frontera WR; Heinemann AW
    Arch Phys Med Rehabil; 2021 Aug; 102(8):1665-1667. PubMed ID: 33991486
    [No Abstract]   [Full Text] [Related]  

  • 3. The Single-Case Reporting Guideline In Behavioural Interventions (SCRIBE) 2016 statement.
    Tate RL; Perdices M; Rosenkoetter U; Shadish W; Vohra S; Barlow DH; Horner R; Kazdin A; Kratochwill T; McDonald S; Sampson M; Shamseer L; Togher L; Albin R; Backman C; Douglas J; Evans JJ; Gast D; Manolov R; Mitchell G; Nickels L; Nikles J; Ownsworth T; Rose M; Schmid CH; Wilson B
    Can J Occup Ther; 2016 Jun; 83(3):184-95. PubMed ID: 27231387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The adaptive designs CONSORT extension (ACE) statement: a checklist with explanation and elaboration guideline for reporting randomised trials that use an adaptive design.
    Dimairo M; Pallmann P; Wason J; Todd S; Jaki T; Julious SA; Mander AP; Weir CJ; Koenig F; Walton MK; Nicholl JP; Coates E; Biggs K; Hamasaki T; Proschan MA; Scott JA; Ando Y; Hind D; Altman DG;
    Trials; 2020 Jun; 21(1):528. PubMed ID: 32546273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized controlled trials in non-pharmacological rehabilitation research: a scoping review of the reporting of sample size calculation, randomization procedure, and statistical analyses.
    Amiri M; Kumbhare D
    Eur J Phys Rehabil Med; 2020 Dec; 56(6):790-798. PubMed ID: 32935956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Adaptive designs CONSORT Extension (ACE) statement: a checklist with explanation and elaboration guideline for reporting randomised trials that use an adaptive design.
    Dimairo M; Pallmann P; Wason J; Todd S; Jaki T; Julious SA; Mander AP; Weir CJ; Koenig F; Walton MK; Nicholl JP; Coates E; Biggs K; Hamasaki T; Proschan MA; Scott JA; Ando Y; Hind D; Altman DG;
    BMJ; 2020 Jun; 369():m115. PubMed ID: 32554564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cochrane Rehabilitation: 2019 annual report.
    Arienti C; Kiekens C; Bettinsoli R; Engkasan JP; Gimigliano F; Grubisic F; Howe T; Ilieva E; Lazzarini SG; Levack WM; Malmivaara A; Meyer T; Oral A; Patrini M; Pollet J; Rathore FA; Negrini S
    Eur J Phys Rehabil Med; 2020 Feb; 56(1):120-125. PubMed ID: 32093464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Single-Case Reporting Guideline In BEhavioural Interventions (SCRIBE) 2016 Statement.
    Tate RL; Perdices M; Rosenkoetter U; Shadish W; Vohra S; Barlow DH; Horner R; Kazdin A; Kratochwill T; McDonald S; Sampson M; Shamseer L; Togher L; Albin R; Backman C; Douglas J; Evans JJ; Gast D; Manolov R; Mitchell G; Nickels L; Nikles J; Ownsworth T; Rose M; Schmid CH; Wilson B
    J Clin Epidemiol; 2016 May; 73():142-52. PubMed ID: 27101888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guidelines for Reporting Outcomes in Trial Protocols: The SPIRIT-Outcomes 2022 Extension.
    Butcher NJ; Monsour A; Mew EJ; Chan AW; Moher D; Mayo-Wilson E; Terwee CB; Chee-A-Tow A; Baba A; Gavin F; Grimshaw JM; Kelly LE; Saeed L; Thabane L; Askie L; Smith M; Farid-Kapadia M; Williamson PR; Szatmari P; Tugwell P; Golub RM; Monga S; Vohra S; Marlin S; Ungar WJ; Offringa M
    JAMA; 2022 Dec; 328(23):2345-2356. PubMed ID: 36512367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reporting guideline for overviews of reviews of healthcare interventions: development of the PRIOR statement.
    Gates M; Gates A; Pieper D; Fernandes RM; Tricco AC; Moher D; Brennan SE; Li T; Pollock M; Lunny C; Sepúlveda D; McKenzie JE; Scott SD; Robinson KA; Matthias K; Bougioukas KI; Fusar-Poli P; Whiting P; Moss SJ; Hartling L
    BMJ; 2022 Aug; 378():e070849. PubMed ID: 35944924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Essential items for reporting of scaling studies of health interventions (SUCCEED): protocol for a systematic review and Delphi process.
    Gogovor A; Zomahoun HTV; Ben Charif A; McLean RKD; Moher D; Milat A; Wolfenden L; Prévost K; Aubin E; Rochon P; Ekanmian G; Sawadogo J; Rheault N; Légaré F
    Syst Rev; 2020 Jan; 9(1):11. PubMed ID: 31926555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methods and results used in the development of a consensus-driven extension to the Consolidated Standards of Reporting Trials (CONSORT) statement for trials conducted using cohorts and routinely collected data (CONSORT-ROUTINE).
    Imran M; Kwakkenbos L; McCall SJ; McCord KA; Fröbert O; Hemkens LG; Zwarenstein M; Relton C; Rice DB; Langan SM; Benchimol EI; Thabane L; Campbell MK; Sampson M; Erlinge D; Verkooijen HM; Moher D; Boutron I; Ravaud P; Nicholl J; Uher R; Sauvé M; Fletcher J; Torgerson D; Gale C; Juszczak E; Thombs BD
    BMJ Open; 2021 Apr; 11(4):e049093. PubMed ID: 33926985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preferred Reporting Items for RAndomized Trials in Endodontics (PRIRATE) guidelines: a development protocol.
    Nagendrababu V; Duncan HF; Bjørndal L; Kvist T; Priya E; Pulikkotil SJ; Jayaraman J; Dummer PMH
    Int Endod J; 2019 Jul; 52(7):974-978. PubMed ID: 30702139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Single-Case Reporting Guideline In BEhavioural Interventions (SCRIBE) 2016 Statement.
    Tate RL; Perdices M; Rosenkoetter U; Shadish W; Vohra S; Barlow DH; Horner R; Kazdin A; Kratochwill T; McDonald S; Sampson M; Shamseer L; Togher L; Albin R; Backman C; Douglas J; Evans JJ; Gast D; Manolov R; Mitchell G; Nickels L; Nikles J; Ownsworth T; Rose M; Schmid CH; Wilson B
    Phys Ther; 2016 Jul; 96(7):e1-e10. PubMed ID: 27371692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development process of a consensus-driven CONSORT extension for randomised trials using an adaptive design.
    Dimairo M; Coates E; Pallmann P; Todd S; Julious SA; Jaki T; Wason J; Mander AP; Weir CJ; Koenig F; Walton MK; Biggs K; Nicholl J; Hamasaki T; Proschan MA; Scott JA; Ando Y; Hind D; Altman DG
    BMC Med; 2018 Nov; 16(1):210. PubMed ID: 30442137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review of guidelines for good practice in decision-analytic modelling in health technology assessment.
    Philips Z; Ginnelly L; Sculpher M; Claxton K; Golder S; Riemsma R; Woolacoot N; Glanville J
    Health Technol Assess; 2004 Sep; 8(36):iii-iv, ix-xi, 1-158. PubMed ID: 15361314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guideline for reporting systematic reviews of outcome measurement instruments (OMIs): PRISMA-COSMIN for OMIs 2024.
    Elsman EBM; Mokkink LB; Terwee CB; Beaton D; Gagnier JJ; Tricco AC; Baba A; Butcher NJ; Smith M; Hofstetter C; Aiyegbusi OL; Berardi A; Farmer J; Haywood KL; Krause KR; Markham S; Mayo-Wilson E; Mehdipour A; Ricketts J; Szatmari P; Touma Z; Moher D; Offringa M
    Health Qual Life Outcomes; 2024 Jul; 22(1):48. PubMed ID: 38978063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guideline for reporting systematic reviews of outcome measurement instruments (OMIs): PRISMA-COSMIN for OMIs 2024.
    Elsman EBM; Mokkink LB; Terwee CB; Beaton D; Gagnier JJ; Tricco AC; Baba A; Butcher NJ; Smith M; Hofstetter C; Aiyegbusi OL; Berardi A; Farmer J; Haywood KL; Krause KR; Markham S; Mayo-Wilson E; Mehdipour A; Ricketts J; Szatmari P; Touma Z; Moher D; Offringa M
    J Patient Rep Outcomes; 2024 Jul; 8(1):64. PubMed ID: 38977535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guideline for reporting systematic reviews of outcome measurement instruments (OMIs): PRISMA-COSMIN for OMIs 2024.
    Elsman EBM; Mokkink LB; Terwee CB; Beaton D; Gagnier JJ; Tricco AC; Baba A; Butcher NJ; Smith M; Hofstetter C; Lee Aiyegbusi O; Berardi A; Farmer J; Haywood KL; Krause KR; Markham S; Mayo-Wilson E; Mehdipour A; Ricketts J; Szatmari P; Touma Z; Moher D; Offringa M
    J Clin Epidemiol; 2024 Sep; 173():111422. PubMed ID: 38849061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methods and processes of the CONSORT Group: example of an extension for trials assessing nonpharmacologic treatments.
    Boutron I; Moher D; Altman DG; Schulz KF; Ravaud P;
    Ann Intern Med; 2008 Feb; 148(4):W60-6. PubMed ID: 18283201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.